MorphoSys Turns To Loss In Q1; Revenues Fall 81%

German biotechnology company MorphoSys AG (MOR,MPSYY.PK) on Wednesday posted first-quarter net loss of 41.6 million euros or 1.27 euros per share, compared to net income of 195.5 million euros or 6.11 euros per share in the same period last year.

Quarterly revenues dropped 81 percent to 47.2 million euros from 251.2 million euros in the previous-year period.

Looking ahead, the company reaffirmed its revenue guidance of 150 million euros to 200 million euros for fiscal year 2021.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Google has revoked its three-year ban on cryptocurrency-related ads on its sites under the search giants' new ad services policy. This action will now allow cryptocurrency exchanges and wallets certified by Google to advertise their products and services on Google's network, beginning August 3, 2021. The UK's competition regulator said Friday that it has secured commitments from Google to address concerns about the tech giant's proposal to remove third-party cookies from Chrome browser. Archer Aviation, a developer of electric vertical take-off and landing or eVTOL aircraft, unveiled its autonomous electric two-seater aircraft, named "Maker", marking a milestone towards its commercial launch. The California-based air mobility company, which has already received orders from United Airlines, will use its inaugural aircraft prototype for testing as it works towards certification.
Follow RTT